FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Slideshows|May 20, 2020
PCPs Report Status as Lockdown Lifts: Results from a National Primary Care Survey
Author(s)Sydney Jennings
Worry is mounting among PCPs about what’s coming after the initial COVID-19 pandemic wave, suggest results from week 8 of the Primary Care Collaborative’s Primary Care & COVID-19 Survey.
Advertisement
The Primary Care Collaborative released the
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Advertisement
Advertisement
Trending on Patient Care Online
1
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
2
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
Unmet Needs and Mechanisms Behind Newer Agitation Therapies
5